Moreover, in several tumor models, such as melanoma, lung, breast, head and neck carcinoma, genetic depletion or pharmacological inhibition of PI3Kγ-induced proinflammatory gene expression in TAMs triggered the infiltration and activation of CD8+ T cells, which in turn reduced tumor growth and metastases [114,115]. This evidence concerns the gene CD8A and melanoma.